Giuseppina Ortu

Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase

Thomas A. Bonasera, Giuseppina Ortu, Yulia Rozen et al. · Nuclear Medicine and Biology · 2001 · 89 citations

Signal Transduction, Signaling Pathway, Potential 18F-labeled Biomarkers +10

The impact of an 8-year mass drug administration programme on prevalence, intensity and co-infections of soil-transmitted helminthiases in Burundi

Giuseppina Ortu, Mohamad Assoum, Udo Wittmann et al. · Parasites & Vectors · 2016 · 77 citations · Full text

Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis

Conrad Muzoora, Kabanda Taseera, Giuseppina Ortu et al. · Journal of Infection · 2011 · 71 citations

Antifungal Agent, Health Sciences, Hiv-associated Cryptococcal Meningitis +10

Labeled EGFr‐TK irreversible inhibitor (ML03): <i>In vitro</i> and <i>in vivo</i> properties, potential as PET biomarker for cancer and feasibility as anticancer drug

Giuseppina Ortu, Iris Ben‐David, Yulia Rozen et al. · International Journal of Cancer · 2002 · 66 citations

Pandemic influenza preparedness in Africa is a profound challenge for an already distressed region: analysis of national preparedness plans

Giuseppina Ortu, Sandra Mounier‐Jack, Richard Coker · Health Policy and Planning · 2008 · 63 citations · Full text

Vaccination, Avian Influenza, Most Plans +13